About Us

CELLGEN BIOPHARMA , based at Delhi, is the fastest growing Pharmaceutical Company in the pharma sector.

Since 2017, CELLGEN BIOPHARMA has been manufacturing, marketing, and exporting Pharmaceutical Products Formulations And Nutraceuticals in the dosage forms of Tablets, Capsules, Oral Liquids, Dry Syrup, Dry Powder & Liquid Injectables, Ointments, Creams, Sachets, Soft Gels, and Ayurvedic Preparations in many therapeutic segments.

With over 30 formulations in our product portfolio, CELLGEN BIOPHARMA is regarded as one of the fastest growingPharmaceutical Companies.

Apart from Indian products (which are registered in India), we also provide patients, doctors, and the pharmaceutical industry with access to unregistered/unavailable medicines to meet unmet medical needs in cases where current medicines options are not available in the country or all other options have been exhausted. We have a network that can function efficiently in a complicated global regulatory environment and ensure that valuable medications are supplied safely and effectively wherever they are needed throughout the product life cycle to achieve this goal.

Cellegen Biopharma is a fast-growing pharmaceutical company that works with a reliable network of pharmaceutical distributors, suppliers, and pharmacies to provide authentic medications (Hepatitis C, Anticancer Medicines, and Innovator Drugs) to patients. Our strength is built on rigorous network distribution partner certification to provide authentic and reliable access to all cancer medications (prescription drugs).

We assist in gaining access to Multinational Original brands introduced in India, Indian generic cancer medications that are far less expensive than branded Innovator brands, and over-the-counter (OTC) healthcare goods.

Why us?

With over a decade of experience in the Indian oncology pharmaceutical industry, we offer our partners unrivalled expertise. Our partners get the benefits of our long-standing reputation for quality, compliance, and customer service.

We have extensive R&D capabilities in-house, but we don't have a monopoly on brilliant ideas. As a result, by 2018, partnerships and strategic acquisitions will account for more than half of our revenue.

External innovation is pursued at all stages of development, from early discovery through late-stage development. We search for innovative solutions that allow our partners to capitalize on their own strengths in every cooperation.

To ensure that collaborations run well, we have a dedicated Alliance Management staff. We want to receive the Alliance Management Award from the Association of Strategic Alliance Professionals — not only for pharmaceutical businesses, but for all sectors.

We know how to work with our R&D partners to create win-win situations that result in successful filings, regulatory clearances, and product launches.

Our domestic as well as worldwide sales and marketing organization, which is notably strong in fast-growing emerging countries, can benefit commercial partners who wish to license or co-market their goods.

We believe in Cellgen Biopharma.